Atlas Trials

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Clinical trial NCT00929955 · COMPLETED

Trial details

NCT number
NCT00929955
Sponsor
Pakistan Institute of Living and Learning
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise SpecifiedSchizophreniform Disorder
Start date
2009-06-01
Primary completion
2009-09-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.